Effect of Ischemic Preconditioning and Propofol on Myocardial Protection in the Globally Ischemic-reperfused Isolated Rat Heart

2004 ◽  
Vol 46 (4) ◽  
pp. 445 ◽  
Author(s):  
Hae Wone Chang ◽  
Choon Hak Lim ◽  
Sung Uk Choi ◽  
Hye Won Lee
Life Sciences ◽  
2003 ◽  
Vol 72 (16) ◽  
pp. 1859-1870 ◽  
Author(s):  
Jean-François Bouchard ◽  
Philippe Lépicier ◽  
Daniel Lamontagne

2000 ◽  
Vol 50 (2) ◽  
pp. 207-213 ◽  
Author(s):  
Kui Hong ◽  
Kengo Fukushima Kusano ◽  
Hiroshi Morita ◽  
Yoshihisa Fujimoto ◽  
Kazufumi Nakamura ◽  
...  

2006 ◽  
Vol 21 (1) ◽  
pp. 44-49 ◽  
Author(s):  
Cristian Leva ◽  
Giovanni Mariscalco ◽  
Sandro Ferrarese ◽  
Vito Domenico Bruno ◽  
Alessandro Orru ◽  
...  

1998 ◽  
Vol 275 (6) ◽  
pp. H2266-H2271 ◽  
Author(s):  
Shuji Kawamura ◽  
Ken-Ichi Yoshida ◽  
Toshiro Miura ◽  
Yoichi Mizukami ◽  
Masunori Matsuzaki

Protein kinase C (PKC) plays an important role in mediating ischemic preconditioning (PC). However, the relationship between PKC isoforms and PC is still uncertain. We analyzed subcellular localization of PKC isoforms by Western blot analysis in isolated rat heart and demonstrate that PKC-α, -δ, and -ε were translocated to the membrane fraction associated with the improvement of cardiac function. Translocation of PKC-δ and -ε persisted after a 30-min period following PC, but the translocation of PKC-α was transient. Under low Ca2+ perfusion (0.2 mmol/l), PC improved the cardiac function associated with the translocation of PKC-δ. Chelerythrine (1.0 μmol/l) suppressed the translocation of all PKC isoforms associated with the loss of improvement of the cardiac function. On the other hand, bisindolylmaleimide (0.1 μmol/l) did not inhibit the improvement of cardiac function induced by PC, which was associated with the translocation of PKC-ε. These results indicate that the effect of PC on cardiac function is mediated by the translocation of either PKC-δ or -ε independently in rat hearts.


Sign in / Sign up

Export Citation Format

Share Document